Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 800-826-4673Fax+1 513-636-2511
Summary
- I specialize in pediatric bone marrow transplant and cellular therapy. I completed my pediatric residency and fellowship in pediatric hematology/oncology at Rady Children's Hospital in San Diego/UCSD, followed by a fellowship in Pediatric Blood and Marrow Transplantation at Cincinnati Children's Hospital Medical Center, where I have stayed on as faculty. My main research interests are in natural killer cell therapies and the impact of the circadian rhythm on my transplant patients.
Education & Training
Cincinnati Children's Hospital Medical CenterPediatric Blood & Marrow Transplantation, 2019 - 2020
University of California (San Diego) Medical CenterFellowship, Pediatric Hematology/Oncology, 2016 - 2019- University of California (San Diego) Medical CenterResidency, Pediatrics, 2013 - 2015
Washington University in St. Louis School of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2014 - 2026
OH State Medical License 2019 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2023 May 05
Publications & Presentations
PubMed
- 13 citationsScheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant.Jeremy D Rubinstein, Carolyn Lutzko, Thomas Leemhuis, Xiang Zhu, Giang Pham
Blood Advances. 2022-05-10 - 40 citationsUmbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.Benjamin H. Goldenson, Huang Zhu, Yunzu Michele Wang, Naveen Heragu, Davide Bernareggi
Frontiers in Immunology. 2020-10-15 - 3 citationsIrradiation‐free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromesYunZu M Wang, Eric Anderson, Nicholas J. Gloude, Ayesha Marion, Catherine King
Pediatric Transplantation. 2021-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
